News

OPM Announces Its 2025 Half-Year Financial Results and Provides an Update on Its Clinical Developments and Financial Position

Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in ...

Mamdani wants a rent freeze. What would that do to the NYC housing market?

Here’s what real estate experts say about the Democratic mayoral candidate’s divisive policy to help New Yorkers living in ...

SCOR - Second quarter 2025 results: EUR 226 million net income in Q2 2025, contributing to a EUR 425 million net income in H1 2025

N° 11 Second quarter 2025 results EUR 226 million net income in Q2 2025, contributing to a EUR 425 million net income in H1 2025 Group net income of EUR 226 million in Q2 2025 driven by all business ...